DANA-FARBER CANCER INSTITUTE INC.;ABBVIE BIOTHERAPEUTICS INC.
发明人:
申请号：
IL24393316
公开号：
IL243933D0
申请日:
2016.02.03
申请国别(地区):
IL
年份:
2016
代理人:
摘要：
Composition suitable for treating multiple myeloma in a subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of being administered in a single or multiple dose regimen.
